Schwab S, Georgiadis D, Berrouschot J, Schellinger P D, Graffagnino C, Mayer S A
Department of Neurology, University of Heidelberg, Germany.
Stroke. 2001 Sep;32(9):2033-5. doi: 10.1161/hs0901.095394.
Moderate hypothermia decreases ischemic damage in experimental stroke models. This multicenter study was performed to evaluate (1) the safety and feasibility of moderate hypothermia and (2) its potential to reduce intracranial hypertension in acute stroke patients.
Fifty prospective patients with cerebral infarction involving at least the complete middle cerebral artery territory treated with moderate hypothermia were evaluated. Hypothermia was induced with the use of cooling blankets as well as alcohol and ice bags within 22+/-9 hours after stroke onset and maintained for 24 to 72 hours; subsequently, patients passively rewarmed over a mean duration of 17 hours. Outcome was assessed at 4 weeks and at 3 months.
Time required for cooling to <33 degrees C varied from 3.5 to 11 hours. The most frequent complications of hypothermic therapy were thrombocytopenia (70%), bradycardia (62%), and pneumonia (48%). Four patients (8%) died during hypothermia as a result of severe coagulopathy, cardiac failure, or uncontrollable intracranial hypertension. An additional 15 patients (30%) died during or after rewarming because of rebound increase in intracranial pressure (ICP) and fatal herniation. A shorter (<16 hours) rewarming period was associated with a more pronounced rise of ICP. Elevated ICP values were significantly reduced under hypothermia. Neurological outcome according to the National Institutes of Health Stroke Scale score 4 weeks after stroke was 29, and Rankin Scale score 3 months after stroke was 2.9.
Moderate hypothermia is feasible in patients with acute stroke, although it is associated with several side effects. Most deaths occur during rewarming as a result of excessive ICP rise. Our preliminary observation that a longer duration of the rewarming period limits the ICP increase remains to be confirmed in future studies.
亚低温可减轻实验性脑卒中模型的缺血性损伤。本多中心研究旨在评估(1)亚低温的安全性和可行性,以及(2)其降低急性脑卒中患者颅内高压的潜力。
对50例前瞻性纳入的大脑梗死至少累及整个大脑中动脉供血区并接受亚低温治疗的患者进行评估。在卒中发作后22±9小时内,使用降温毯以及酒精和冰袋诱导体温降低,并维持24至72小时;随后,患者被动复温,平均持续时间为17小时。在4周和3个月时评估结局。
冷却至<33℃所需时间为3.5至11小时。低温治疗最常见的并发症为血小板减少(70%)、心动过缓(62%)和肺炎(48%)。4例患者(8%)在低温治疗期间因严重凝血病、心力衰竭或无法控制的颅内高压死亡。另外15例患者(30%)在复温期间或复温后因颅内压(ICP)反弹升高和致命性脑疝死亡。较短的(<16小时)复温期与更明显的ICP升高相关。低温治疗期间ICP升高值显著降低。卒中后4周根据美国国立卫生研究院卒中量表评分的神经功能结局为29分,卒中后3个月改良Rankin量表评分为2.9分。
亚低温对急性脑卒中患者可行,尽管会伴有一些副作用。大多数死亡发生在复温期间,原因是ICP过度升高。我们初步观察到较长的复温期可限制ICP升高,这一观察结果有待未来研究证实。